Healthy high growth potential

Results

1484

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1484 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
KEBNI B
SEK 1.04-13.3%-51.1%SEK 286.1mSEK 1.602.582.7%n/aTech
RHM
€1,093.4015.5%-37.7%€50.9b€1,741.3548.530.6%1.1%Capital Goods
NVDA
US$194.831.2%22.3%US$4.7tUS$301.6229.622.2%0.5%Semiconductors
CORT
US$90.213.3%24.8%US$9.7bUS$88.00207.548.9%n/aPharmaceuticals & Biotech
SAUD3
R$14.622.4%24.6%R$42.7bR$16.2175.741.6%5.6%Healthcare
AGP
€7.253.6%-5.6%€132.2m€8.5726.639.1%n/aCapital Goods
MOD
US$230.97-9.8%120.9%US$12.2bUS$340.86100.449.3%n/aCapital Goods
MX1
AU$0.03612.5%-20.0%AU$26.9mAU$0.151.6105.5%n/aHealthcare
002810
CN¥25.526.8%97.5%CN¥8.8bCN¥36.0044.243.1%1.6%Materials
CRDO
US$241.911.6%158.4%US$45.1bUS$269.8195.527.5%n/aSemiconductors
A458870
₩36,250.0012.6%279.6%₩1.4t₩69,000.0045.341.5%n/aHealthcare
688192
CN¥48.4832.9%-26.3%CN¥22.6bCN¥83.0025.2105.9%n/aPharmaceuticals & Biotech
LITE
US$728.32-10.9%685.3%US$56.7bUS$1,111.29129.179.1%n/aTech
MONOLITH
₹777.753.6%151.2%₹16.9b₹960.0073.437.2%n/aMaterials
4417
JP¥4,210.0027.2%41.3%JP¥63.3bJP¥4,500.0042.624.1%0.8%Software
2480
HK$12.74-0.5%-47.1%HK$2.5bHK$31.003.377.1%n/aPharmaceuticals & Biotech
688072
CN¥832.000%425.9%CN¥234.1bCN¥511.08142.435.2%0.04%Semiconductors
002970
CN¥54.25-1.7%9.7%CN¥9.9bn/a30.336.5%1.8%Automobiles
002384
CN¥232.73-10.6%446.3%CN¥424.2bCN¥157.50207.973.1%0%Tech
MDGL
US$528.103.0%76.7%US$12.2bUS$678.7110.859.2%n/aPharmaceuticals & Biotech
501423
₹2,901.851.8%78.7%₹133.5b₹3,517.6778.633.7%0.1%Capital Goods
ADMR
Rp1,445.005.9%50.5%Rp59.1tRp2,343.6411.226.8%3.3%Materials
2455
NT$358.002.9%180.8%NT$66.2bNT$387.30113.045.8%0.7%Semiconductors
CDR
zł233.407.4%-13.5%zł23.3bzł235.1345.229.7%0.4%Media
Page 1 of 42